Based on these findings the authors suggested that, in ADPKD, kidney damage and reduced urine concentrating capacity determine copeptin levels and that kidney function per se is not the leading determinant of the serum copeptin concentration. Here, AVP is linked to autosomal dominant polycystic kidney disease.